Impact of testosterone treatment on postprandial triglyceride metabolism in elderly men with subnormal testosterone levels

References

• Godsland I. F., Wynn V., Crook D., Miller N. E. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J 1987; 114: 1467–503
   PubMed Web of Science ®Google Scholar
• Lichtenstein M. J., Yarnell J. W., Elwood P. C., Beswick A. D., Sweetnam P. M., Marks V., et al. Sex hormones, insulin, lipids, and prevalent ischemic heart disease. Am J Epidemiol 1987; 126: 647–57
   PubMed Web of Science ®Google Scholar
• Khaw K. T., Barrett‐Connor E. Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men. Arterioscler Thromb 1991; 11: 489–94
   PubMed Web of Science ®Google Scholar
• Bansal S., Buring J. E., Rifai N., Mora S., Sacks F. M., Ridker P. M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. J Am Med Assoc 2007; 298: 309–16
   PubMed Web of Science ®Google Scholar
• Nordestgaard B. G., Benn M., Schnohr P., Tybjaerg‐Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. J Am Med Assoc 2007; 298: 299–308
   PubMed Web of Science ®Google Scholar
• Patsch J. R., Miesenbock G., Hopferwieser T., Muhlberger V., Knapp E., Dunn J. K., et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992; 12: 1336–45
   PubMed Web of Science ®Google Scholar
• Boquist S., Ruotolo G., Tang R., Bjorkegren J., Bond M. G., de Faire U., et al. Alimentary lipemia, postprandial triglyceride‐rich lipoproteins, and common carotid intima‐media thickness in healthy, middle‐aged men. Circulation 1999; 100: 723–8
   PubMed Web of Science ®Google Scholar
• Bjorkegren J., Boquist S., Samnegard A., Lundman P., Tornvall P., Ericsson C. G., et al. Accumulation of apolipoprotein C‐I‐rich and cholesterol‐rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease. Circulation 2000; 101: 227–30
   PubMed Web of Science ®Google Scholar
• Agledahl I., Skjaerpe P. A., Hansen J. B., Svartberg J. Low serum testosterone in men is inversely associated with non‐fasting serum triglycerides: The Tromso Study. Nutr Metab Cardiovasc Dis 2007
   PubMed Web of Science ®Google Scholar
• Agledahl I., Hansen J. B., Svartberg J. Postprandial triglyceride metabolism in elderly men with subnormal testosterone levels. Asian J Androl 2008, In press
   PubMed Web of Science ®Google Scholar
• Nordoy A., Bonaa K. H., Sandset P. M., Hansen J. B., Nilsen H. Relationship between apolipoprotein E polymorphism, postprandial hyperlipemia and hemostatic variables in patients with combined hyperlipemia. Nutr Metab Cardiovasc Dis 2000; 10: 15–23
   PubMed Web of Science ®Google Scholar
• Vermeulen A., Verdonck L., Kaufman J. M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666–72
   PubMed Web of Science ®Google Scholar
• Olivecrona T., Bengtsson‐Olivecrona G., Ostergaard P., Liu G., Chevreuil O., Hultin M. New aspects on heparin and lipoprotein metabolism. Haemostasis 1993; 23(Suppl 1)150–60
   PubMedGoogle Scholar
• Hislop M. S., St Clair Gibson A., Lambert M. I., Noakes T. D., Marais A. D. Effects of androgen manipulation on postprandial triglyceridaemia, low‐density lipoprotein particle size and lipoprotein(a) in men. Atherosclerosis 2001; 159: 425–32
   PubMed Web of Science ®Google Scholar
• Jang Y., Kim O. Y., Ryu H. J., Kim J. Y., Song S. H., Ordovas J. M., et al. Visceral fat accumulation determines postprandial lipemic response, lipid peroxidation, DNA damage, and endothelial dysfunction in nonobese Korean men. J Lipid Res 2003; 44: 2356–64
   PubMed Web of Science ®Google Scholar
• Svartberg J., von Muhlen D., Sundsfjord J., Jorde R. Waist circumference and testosterone levels in community dwelling men. The Tromso Study. Eur J Epidemiol 2004; 19: 657–63
   PubMed Web of Science ®Google Scholar
• Volek J. S., Gomez A. L., Kraemer W. J. Fasting lipoprotein and postprandial triacylglycerol responses to a low‐carbohydrate diet supplemented with n‐3 fatty acids. J Am Coll Nutr 2000; 19: 383–91
   PubMed Web of Science ®Google Scholar
• Gill J. M., Al‐Mamari A., Ferrell W. R., Cleland S. J., Packard C. J., Sattar N., et al. Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men. J Am Coll Cardiol 2004; 44: 2375–82
   PubMed Web of Science ®Google Scholar
• Svartberg J. Epidemiology: testosterone and the metabolic syndrome. Int J Impot Res 2007; 19: 124–8
   PubMed Web of Science ®Google Scholar
• Makhsida N., Shah J., Yan G., Fisch H., Shabsigh R. Hypogonadism and metabolic syndrome: implications for testosterone therapy. J Urol 2005; 174: 827–34
   PubMed Web of Science ®Google Scholar
• Niskanen L., Laaksonen D. E., Punnonen K., Mustajoki P., Kaukua J., Rissanen A. Changes in sex hormone‐binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome. Diabetes Obes Metab 2004; 6: 208–15
   PubMed Web of Science ®Google Scholar
• Jones R. D., Nettleship J. E., Kapoor D., Jones H. T., Channer K. S. Testosterone and atherosclerosis in aging men: purported association and clinical implications. Am J Cardiovasc Drugs 2005; 5: 141–54
   PubMedGoogle Scholar
• Haddad R. M., Kennedy C. C., Caples S. M., Tracz M. J., Bolona E. R., Sideras K., et al. Testosterone and cardiovascular risk in men: a systematic review and meta‐analysis of randomized placebo‐controlled trials. Mayo Clin Proc 2007; 82: 29–39
   PubMed Web of Science ®Google Scholar
• Krause W., Mueller U., Mazur A. Testosterone supplementation in the aging male: which questions have been answered?. Aging Male 2005; 8: 31–8
   PubMedGoogle Scholar
• Whitsel E. A., Boyko E. J., Matsumoto A. M., Anawalt B. D., Siscovick D. S. Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta‐analysis. Am J Med 2001; 111: 261–9
   PubMed Web of Science ®Google Scholar
• Calof O. M., Singh A. B., Lee M. L., Kenny A. M., Urban R. J., Tenover J. L., et al. Adverse events associated with testosterone replacement in middle‐aged and older men: a meta‐analysis of randomized, placebo‐controlled trials. J Gerontol A Biol Sci Med Sci 2005; 60: 1451–7
   PubMed Web of Science ®Google Scholar
• Gruenewald D. A., Matsumoto A. M. Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc 2003; 51: 101–15, discussion 115
   PubMed Web of Science ®Google Scholar
• Isidori A. M., Giannetta E., Greco E. A., Gianfrilli D., Bonifacio V., Isidori A., et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle‐aged men: a meta‐analysis. Clin Endocrinol (Oxf) 2005; 63: 280–93
   PubMed Web of Science ®Google Scholar
• Karpe F., Steiner G., Olivecrona T., Carlson L. A., Hamsten A. Metabolism of triglyceride‐rich lipoproteins during alimentary lipemia. J Clin Invest 1993; 91: 748–58
   PubMed Web of Science ®Google Scholar
• Koba S., Hirano T., Sakaue T., Takeuchi H., Adachi M., Katagiri T. An increased number of very‐low‐density lipoprotein particles is strongly associated with coronary heart disease in Japanese men, independently of intermediate‐density lipoprotein or low‐density lipoprotein. Coron Artery Dis 2002; 13: 255–62
   PubMed Web of Science ®Google Scholar
• Carlsson M., Wessman Y., Almgren P., Groop L. High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 2000; 20: 1588–94
   PubMed Web of Science ®Google Scholar
• Pirro M., Mauriege P., Tchernof A., Cantin B., Dagenais G. R., Despres J. P., et al. Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Atherosclerosis 2002; 160: 377–84
   PubMed Web of Science ®Google Scholar
• Dixon J. L., Furukawa S., Ginsberg H. N. Oleate stimulates secretion of apolipoprotein B‐containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J Biol Chem 1991; 266: 5080–6
   PubMed Web of Science ®Google Scholar
• Kissebah A. H., Alfarsi S., Adams P. W., Wynn V. The metabolic fate of plasma lipoproteins in normal subjects and in patients with insulin resistance and endogenous hypertriglyceridaemia. Diabetologia 1976; 12: 501–9
   PubMed Web of Science ®Google Scholar
• Patsch J. R., Prasad S., Gotto A. M., Jr., Patsch W. High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987; 80: 341–7
   PubMed Web of Science ®Google Scholar
• Marin P., Oden B., Bjorntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab 1995; 80: 239–43
   PubMed Web of Science ®Google Scholar